
Hera is developing the 1st non-surgical test for diagnosis and staging of #endometriosis.
San Antonio, TX
Joined January 2022
- Tweets494
- Following101
- Followers106
- Likes100
Pinned Tweet
Hera’s goal is to commercialize MetriDx™, a non-surgical test to stage and diagnose #endometriosis that uses the patient's endometrial cells which are
collected during an in-office, minimally invasive procedure that eliminates the need for a surgical biopsy.
Behind every brave smile, there's a silent struggle. Living with endometriosis is more than painful periods; it's battling through work, school, and daily life.
#EndometriosisAwareness #FromSurgicalToSimple
Understanding these connections is crucial for advancing women's health research. Together, let's raise awareness and support ongoing studies. 💗🔬
#WomenHealth #FromSurgicalToSimple
Exciting news! 🌟 Our CEO, Somer Baburek, is featured in In Vivo discussing Hera Biotech's revolutionary diagnostic tool. Thrilled to share how we're advancing healthcare with innovation and dedication. Read more here: invivo.citeline.com/IV154639…
#HeraBiotech #FromSurgicalToSimple
Meet Bruce Nicholson: a decorated researcher, and a pioneer in the field of connexin research! 🌟 With over 40 years dedicated to unraveling their function and co-inventor of the technology, Bruce brings a wealth of knowledge here at Hera Biotech!
#FromSurgicalToSimple
We're humbled and honored to receive multiple awards for our dedication to women's health!🌟 Continuing our mission Hera Biotech is focused on pioneering the first non-surgical diagnostic test for endometriosis.💙
#FromSurgicalToSimple
Empowering women's health through innovation 💪 At Hera Biotech, we're dedicated to closing diagnostic gaps and transforming care. Together, we're paving the way for a healthier future for all women.
#FromSurgicalToSimple
🔬💫 Hera Biotech's groundbreaking method skips surgery, instead analyzing endometrial tissue for gene expression changes linked to the condition. Visit our website to learn more: herabiotech.com/
#EndometriosisDiagnosis #FromSurgicalToSimple
Endometriosis surgery costs can be daunting, but Hera Biotech is pioneering a game-changing solution to make diagnosing more accessible than ever. 💪 Connect with us and stay tuned for a future where healthcare is more affordable and inclusive!
#FromSurgicalToSimple
Meet Paul Castella🌟 As Co-Founder and Board Chairman, his visionary leadership has propelled Hera to the forefront of biotech. With a stellar track record including multiple successful exits, Paul's expertise is unmatched!
#FromSurgicalToSimple
Hera's team brings a wealth of knowledge in medical diagnostics development, approval, and more. MetriDx™, the groundbreaking diagnostic test for endometriosis, will expand access for OB/GYNs and fertility clinics.
#FromSurgicalToSimple
Did you know there are incredible support groups like Endometriosis Association, EndoFound, SpeakEndo, and many more? Connect with others who understand your journey, share experiences, and access invaluable resources. You're not alone. 💛
#FromSurgicalToSimple
Did you know that 1 in 10 women worldwide grapple with endometriosis? It's not just about pain; this condition also affects women between ages between 15-49 years, and up to 50% of women who are infertile.
#FromSurgicalToSimple
Living with endometriosis can be challenging, but it's not impossible. 💪 Embrace self-care, seek support, talk to your doctor, and educate yourself about managing symptoms.
#EndometriosisAwareness #FromSurgicalToSimple
Meet Somer Baburek, the powerhouse Co-Founder and CEO of Hera Biotech!🌟 With a proven track record in life science start-ups, Somer brings unparalleled expertise in Rx drug development, clinical operations, FDA regulation, and achieving successful exits.
#FromSurgicalToSimple
We are pleased to announce that Somer Baburek has been recognized as a 2024 Women's Leadership Awards Honoree by the San Antonio Business Journal. Cheers to celebrating her remarkable achievements!
#WomenLeaders #FromSurgicalToSimple
Ladies, listen up! Endometriosis affects millions of women worldwide, with symptoms ranging from mild discomfort to debilitating pain. No matter how minor or vague your symptoms may seem, it's crucial to speak up and share with your doctor.
#FromSurgicalToSimple
Hera Biotech is pioneering MetriDx, a game-changing technology for a nonsurgical diagnostic test. By taking diagnosis out of the operating room, we're making strides towards earlier detection and improving endometriosis diagnosis.💫
#EndometriosisAwareness #FromSurgicalToSimple
Endometriosis isn't just a health issue, it's an economic burden too. The direct medical care for this condition adds up, often impacting financial stability.
#EndometriosisAwareness #FromSurgicalToSimple
Understanding an individual's endometriosis status is crucial for tailored and effective medical intervention. Let's break the silence and prioritize informed care for everyone affected.
#FromSurgicalToSimple #EndometriosisAwareness
Empowering women's health through innovation! 🌟 At Hera Biotech, we're dedicated to pioneering a nonsurgical diagnostic test to revolutionize women's healthcare. Every day, our research team pushes boundaries to create impactful solutions.
#FromSurgicalToSimple





















